Fig. 1From: The role of leukotriene inhibition using a 5-lipoxygenase (5-LO) inhibitor in a joint contracture modelThe eicosanoid pathway including relative metabolites and effects. Highlighted in red are the various treatment modalities that inhibit parts of this pathway. Metabolites include prostaglandin I2 (PGI2), thromboxane A2 (TXA2), and leukotrienes B4, C4, D4, and E4 (LTB4, C4, D4 and E4)Back to article page